The transfer of sialic acids (Sia) from CMP-sialic acid (CMP-Sia) to N-linked sugar chains is thought to occur as a final step in their biosynthesis in the trans portion of the Golgi apparatus. In some cell types such Sia residues can have 0-acetyl groups added to them. We demonstrate here that rat hepatocytes express 9-0-acetylated Sias mainly at the plasma membranes of both apical (bile canalicular) and basolateral (sinusoidal) domains. Golgi fractions also contain 9-0-acetylated Sias on similar N-linked glycoproteins, indicating that 0-acetylation may take place in the Golgi. We show here that CMP-Sia-FITC (with a fluorescein group attached to the Sia) is taken up by isolated intact Golgi compartments. In these preparations, Sia-FITC is transferred to endogenous glycoprotein acceptors and can be immunochemically detected in situ. Addition of unlabeled UDP-Gal enhances Sia-FITC incorporation, indicating a substantial overlap of ,3-galactosyltransferase and sialyltransferase machineries. Moreover, the same glTcoproteins that incorporate Sia-FITC also accept [3H]galactose from the donor UDP-[ H]Gal. In contrast, we demonstrate with three different approaches (double-labeling, immunoelectron microscopy, and addition of a diffusible exogenous acceptor) that sialyltransferase and O-acetyltransferase machineries are much more separated from one another. Thus, 9-0-acetylation occurs after the last point of Sia addition in the trans-Golgi network. Indeed, we show that 9-0-acetylated sialoglycoproteins are preferentially segregated into a subset of vesicular carriers that concentrate membrane-bound, but not secretory, proteins.
INTRODUCTION
apparatus (Kornfeld and Kornfeld, 1985; Griffiths and Simons, 1986; Roth, 1991) . Compartmental organiza-N-linked glycan biosynthesis is a complex process tion of the Golgi apparatus has been described as a occurring in an ordered manner in defined compart-function of the glycosidases and glycosyltransferases ments of the endoplasmic reticulum (ER) and Golgi contained in different cisternae (Goldberg and Kornfeld, 1983; Quinn et al., 1983; Rothman, to sialic acids at both 7-and 9-positions. Each of these reactions can be recapitulated in vitro by adding labeled nucleotides to isolated intact Golgi preparations. The dotted lines emphasize the question addressed in this study: Do the compartments mediating these reactions overlap functionally?
dogenous sugar nucleotide-degrading enzymes can regulate the internal pools of the donor (Martina et al., 1995) . Thus, specific transferases, nucleotide donors, and glycoconjugate acceptors coexisting in a Golgi compartment comprise the basic elements of the glycosylation machinery (see Figure 1 ). However, relatively little is known about the distribution of factors other than the transferases. We have recently shown that the coordinated action of these components of the glycosylation machinery can be recapitulated in in vitro "freeze-frame" reactions, which are initiated by labeling the endogenous glycoprotein acceptors in rat liver Golgi preparations with radioactive nucleotide donors (Hayes et al., 1993; Hayes and Varki, 1993a,b) . In these preparations, intercompartmental transport is absent, and the glycosylation reactions mediated by the exogenously added donors take place primarily in sealed compartments of the correct topological orientation. Thus, nonfunctional compartments or other subcellular contaminants do not interfere.
Sialic acids (Sia)' are a family of negatively charged sugars, usually found at the terminal position in animal glycans (Varki, 1992) . Sialylation is usually considered the final step in the glycosylation of N-and 0-linked oligosaccharides and is believed to occur either in the trans-cisternae or in the trans-Golgi network (TGN; Roth et al., 1985 Roth et al., , 1986 . However, Sia residues can be further modified by the addition of 0-acetyl groups, most commonly at the 9-position of the side chain (Varki, 1992) . These modifications of sialic acids can affect a variety of biological phenomena, including complement activation (Varki and Kornfeld, 1980) , viral pathogenesis (Schultze and Herrler, 1994; Zimmer et al., 1995) , embryonic development (Blum and Barnstable, 1987; Varki et al., 1991) , and the formation of tumor antigens (Cheresh et al., 1984) . With the development of improved analytical techniques (Schauer, 1987; Manzi et al., 1990a) and better probes for their detection (Klein et al., 1994; Zimmer et al., 1994) , modifications of Sia were more widespread than previously thought (Klein et al., 1994) . For example, we have shown that a2-6-linked Sia residues on N-linked chains of rat liver glycoproteins carry extensive 0-acetylation at the 7-and 9-positions (Butor et al., 1993) .
0-acetyl residues are first transferred to Sias that are already incorporated into N-linked chains (Butor et al., 1993 . The polypeptide(s) responsible for this transfer reaction have so far resisted all attempts at purification or molecular cloning. Thus, the subcellular location of 0-acetylation remains unknown. Sialylation can also be recapitulated in vitro in the same intact cytosol-free rat liver Golgi preparations by adding CMP-[3H]Sia (Hayes and Varki, 1993b (Gross and Brossmer, 1988) to follow the sialylation reaction and a recently described recombinant probe derived from the Influenza C hemagglutinin-esterase (Klein et al., 1994) (Higa and Paulson, 1985; Manzi et al., 1990b (Saucan and Palade, 1994 ) have been previously described and characterized. Anti-rat a2-6sialyltransferase was a kind gift from Dr. K. Colley (University of Chicago, IL).
Isolation of Golgi Apparatus-enriched Subcellular Fraction
Golgi compartments from rat liver were purified by following Leelavathi's procedure (Leelavathi et al., 1970) , as modified by Tabas and Komfeld (Tabas and Komfeld, 1979) . The Golgi-enriched fraction (typically 50-100-fold enriched for ,B-galactosyltransferase activity) was collected from the interface between 1.0 and 0.5 M sucrose solutions of the second gradient step. This preparation was used without further washing after serial dilution with maleate buffer to the range of 0.6 M of sucrose, which was optimal for both biochemical and ultrastructural studies, including preservation of cisternal morphology. The final preparation was also routinely treated with 1 mM DFP (Muchmore and Varki, 1987) (Etchison et al., 1995) . Material bound and eluted from the cartridge was then analyzed in a C18 reverse-phase high performance liquid chromatography (HPLC) on a 4.6 x 25 cm Microsorb MV-C18 column (Rainin, Emeryville, CA).
The column was eluted isocratically with 0.1 M NH4COOH pH 6 for 5 min, followed by a 0-50% methanol gradient in the same buffer over 45 min at a flow rate of 1.0 ml/min. Fractions (1 ml) were collected and radioactivity was monitored by liquid scintillation counting. In some experiments, the radiolabeled 4-MU derivatives were purified for further analysis of the labeled Sias, which were released by either sialidase treatment or mild acid hydrolysis with 2 M acetic acid at 80°C for 2 h (Manzi et al., 1990a) . Sialidase treatment was done with either Arthrobacter ureafaciens sialidase (Calbiochem, La Jolla, CA) or Newcastle disease virus sialidase as described (Powell and Varki, 1996) . Released Sias were purified by reapplication to a C18 SPICE cartridge, which no longer retained the label.
Free sialic acids in the run-through fractions were dried, resuspended in 20 ,lI of distilled water, treated or not with 0.1 M NaOH at 37°C for 15 min for de-O-acetylation, and separated in a descending paper chromatography system with Whatman 3 MM paper eluted with pyridine:ethyl acetate:acetic acid:water (5:5:1:3) for 16 h.
In this system, Neu5Ac separates from Neu5,9Ac2 and other modified sialic acids. After the run, strips of 1 cm were cut and soaked in 400 ,ul of water, and radioactivity was monitored by liquid scintillation counting.
Immunoisolation of Vesicular Carriers
Rat liver Golgi light fractions were processed through immunoisolation with magnetic beads coated with an antibody against the carboxy terminus of the polymeric IgA receptor (pIgA-R), essentially as described (Saucan and Palade, 1994) . Starting material, nonbound, and bound fractions were solubilized in Laemmli sample buffer, separated in SDS-polyacrylamide gels, transferred to nitrocellulose, and analyzed by means of Western blots with an anti-pIgA-R, Sambucus nigra agglutinin (SNA lectin), and CHE-FcD, as described above. Protein loading was done in such a way that the amount studied from the starting material was the sum of both bound (-10-20% of total protein) and nonbound (-80-90% of total protein) fractions, as described (Saucan and Palade, 1994) .
RESULTS
Rat Hepatocytes Express 9-0-Acetylated Sialic Acids at both Apical and Basolateral Plasma Membranes We recently described a recombinant soluble probe (Klein et al., 1994) derived by fusing the extracellular domain of the Influenza C-hemagglutinin esterase to the hinge and Fc portion of the human IgG heavy chain (CHE-Fc). This probe retains both the esterase and hemagglutinin functions of the viral glycoprotein, which is known to recognize and degrade 0-acetyl groups on 9-0-acetylated sialic acids, regardless of their underlying linkage (Herrler et al., 1985; Rogers et al., 1986) . Irreversible inactivation of the esterase with diisopropyl fluorophosphate (DFP) gives the derivative CHE-FcD, which retains the hemagglutinin activity. This molecule can be used to detect 9-0-acetylated sialic acids on tissue sections and Western blots of glycoproteins (Klein et al., 1994) . The unmodified CHE-Fc molecule can be used as a nonbinding control for the CHE-FcD probe, because the esterase activity is dominant at RT. Using the CHE-FcD probe for immunohistochemistry on cryostat sections at the light microscopic level, we previously showed that rat liver sections showed strong staining. However, the relative distribution of the 9-0-acetylation among the various cell types could not be determined precisely (Klein et al., 1994) . When semithin sections of rat liver were probed with CHE-FcD and a fluorescent secondary antibody, staining seemed to be concentrated primarily at the plasma membrane of hepatocytes, mainly at the level of basolateral (sinusoidal) domains (see examples in Figure 2 , A and B). A weaker reactivity with CHE-FcD could also be seen 
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.4., ,,: .mS ,%; X * " ' P 6 s g t : 6 3 ; i b X < e @ *q # . ' . 3 ' ' , ! ? ' ' Immunofluorescence of semithin 0.5-1.0-Am cryosections of rat liver with a probe for 9-0-acetylated sialic acids (CHE-FcD) and its control (CHE-Fc) Figure 2, A and B). The specificity of the labeling for 9-0-acetylated sialic acids was confirmed by the lack of signal with CHE-Fc (Figure 2, C and D) . The presence of 9-0-acetylated sialoglycoconjugates in both apical (Figure 2E) and basolateral ( Figure 2F) (Hayes et al., 1993) . However, the resolution of tritium autoradiography is insufficient to determine morphologically whether both reactions had taken place in the same compartments. Substitutions at the 9-position of the CMP-Sia do not affect the ability of some sialyltransferases to use it as a donor for sialylation reactions (Gross and Brossmer, 1988) . For example, the modified nucleotide CMP-9-fluoresceinylNeu5Ac (CMP-Sia-FITC) was shown to be capable of donating FITC to endogenous glycoproteins in permeabilized CHO cells (Gross, 1992) . We reasoned that if CMP-Sia-FITC were transported correctly into the lumen of isolated rat liver Golgi compartments, it could act as a donor for sialylation of endogenous glycoprotein intermediates. The sites of incorporation of Sia-FITC could then be identified with a polyclonal monospecific antibody directed against FITC. We first optimized conditions to allow for both immunocytochemical and biochemical studies. Golgi stacks were found by EM to be well-maintained at a sucrose concentration of 0.6 M, which is close to the initial concentration obtained when the fresh preparations are removed directly from the final sucrose step gradient. Golgi preparations were therefore adjusted to 0.6 M sucrose with maleate buffer for all assays. Under these conditions, uptake Figure 4B are represented in Figure 5A . Because these Golgi preparations are cytosol-free and therefore incapable of intercompartmental transport (Kagiwada et al., 1993) , these results provide evidence for the functional colocalization of ,B-galactosyltransferase and sialyltransferase activities. These same Golgi preparations contain sialoglycoproteins that are 9-0-acetylated (see Figure 3) , and a functional 0-acetylation reaction can be demonstrated within the sealed compartments by labeling with [3H]acetylCoA, which fives incorporation of label almost exclusively into [ H]O-acetyl-sialic acids Hayes and Varki, 1993b Figure 5B , up to 70% of the [3H]Gal labeled in glycoconjugates could be immunoprecipitated by the anti-FITC antibodies, indicating that these newly galactosylated glycoconjugates could also be substituted by Sia-FITC in the same Golgi compartments. On the other hand, <5% of the [3Hlacetyl-CoA-labeled glycoconjugates were immunoprecipitated after four consecutive rounds of the immunoprecipitation procedure. This means either that the compartments of sialylation and 0-acetylation are distinct or that the target molecules for the two reaction are different. However, as mentioned above, our previous work . Thus, although the same Golgi compartments contain the majority of the functional galactosylation and sialylation machineries, the compartment of 0-acetylation seems to be relatively distinct.
O-Acetylated Sialoglycoconjugates Are Segregated from Newly Synthesized Sialoglycoconjugates in the Golgi Preparations In parallel with the biochemical studies described above, paired samples were routinely prepared for immunoelectron microscopy. Immunoelectron microscopy studies were performed with an antibody against FITC and the CHE-FcD probe, each detected with appropriate gold conjugates of two different sizes. 9-0-Acetylated Sia residues (detected with 10 nm of gold goat anti-human IgG conjugates) tended to accumulate in vesicle-like structures in the TGN or in the rims of trans-most cisternae of the Golgi stacks ( Figure 6A ). The specificity of this result was confirmed by the absence of labeling with the unmodified CHE-Fc molecule ( Figure 6B ). The sites of incorporation of Sia-FITC were found to be discrete areas within and adjacent to the Golgi stacks ( Figure 6, C and D) .
We next performed a series of double-labeling studies with gold particles of different sizes. Sites of 0-acetylated sialoglycoproteins were labeled with 10 nm of gold goat anti-human IgG conjugates, whereas sites of Sia-FITC incorporation were labeled with 5 nm of gold goat anti-rabbit conjugates. Some representative examples of the results are shown in Figure 7 . A clear segregation of 0-acetylated sialoglycoconjugates (detected by CHE-FcD) from the compartment of sialylation (sites of Sia-FITC incorporation) was observed ( Figure 7, A and B) . The extent of segregation was quantitated by counting -4500 beads on several independent sections. In 85% of membranous structures studied, there was complete separation of the different-sized gold particles. Among the remaining 15% of the structures, more than one-half represent situations showing a substantial enrichment of only one size or another of the gold particles. This segregation persisted even when both 0-acetylation and sialylation were driven to a maximum extent possible by preincubation with saturating UDP-Gal and acetyl-CoA (final 10 ,tM and 30 ptM, respectively) before adding CMP-Sia-FITC.
The orientation of the Golgi stacks could be determined by double-labeling with antibodies directed either against a2-6sialyltransferase ( Figure 7C ), which has been previously localized to the trans-Golgi compartment and the TGN in rat hepatocytes (Roth et al., 1985) , or against a-mannosidase II ( Figure 7D ), which is concentrated in the medial Golgi stacks of the same (Velasco et al., 1993) . Approximately 42% of CHEFcD-positive areas (large gold particles) colocalized with sialyltransferase-positive areas (small gold particles, Figure 7C ). In contrast, there was little overlap of a-mannosidase II labeling with the actual sites of CHE-FcD labeling (-12%, see Figure 7D ) or with Sia-FITC incorporation (our unpublished results). Thus, distribution of sialyltransferase was broader than the distribution of Sia-FITC incorporation. This supports the concept that the presence of the enzyme per se does not necessarily define a functional Golgi compartment (Hayes et al., 1993) . Taken together, both biochemical and ultrastructural data indicate that the functional compartments of sialylation (sites of Sia-FITC labeling) and 0-acetylation (both pre-existing endogenous residues and those generated by the addition of excess acetyl-CoA) are substantially, if not completely, distinct.
Lactose-4 MU Is an Exogenous Acceptor for Sialyltransferase Action in Intact Golgi Compartments
Because the CMP-Sia-FITC donor has FITC linked to C9 oft Sia, such residues cannot be 9-0-acetylated.
However, the endogenous internal pool of CMP-Sia in fresh Golgi preparations (Hirschberg and Snider, 1987) No 0-acetylated sialic acid was observed under these conditions (our unpublished results). It could be questioned whether the presence of the 9-FITC groups on some Sia residues might somehow restrict 0-acetylation on other Sia residues. However, such steric hindrance is unlikely, because the different antennae of multiantennary N-linked oligosaccharides have considerable range of mobility in solution (Carver et al., 1989) . Regardless, we decided to take one more independent approach to this issue, studying the possibility of the 0-acetylation reaction occurring on an exogenous acceptor present in all compartments of sialylation. This acceptor must be introduced without disrupting compartment integrity. Such an approach recently had been presented (Etchison et al., 1995) , wherein similar rat liver Golgi preparations were incubated with the diffusible derivative 4-methylumbelliferyl,3-xyloside. This exogenous acceptor crossed the Golgi membrane and was elongated by endogenous glycosyltransferases; a sialylated subset was found to be trapped inside the compartments of synthesis (Etchison et al., 1995) . We chose 4-methylumbelliferylf3-lactoside to function as an acceptor for the sialyltransferases of rat liver. As shown in Figure 8A , this molecule did undergo addition of radiolabeled Sia residues from CMP-[3H]Sia, giving a product that was trapped inside the compartments and, after release, was bound to a hydrophobic C18 cartridge. This sialylation of 4-MU-lactose was saturable ( Figure 8A ), reaching a maximum with a 5 mM exogenous concentration.
The newly sialylated 4-MU-lactoside molecules trapped inside the Golgi compartments were collected by centrifugation, released by ethanol extraction, and purified by reverse-phase chromatography with the use of either C18 cartridges or a C18 HPLC column. As shown in Figure 8B , the sialylated material gave a single major peak on the latter column. Differential sensitivity to sialidases from A. ureafaciens (cleaves sialic acids in all linkages) and Newcastle disease virus (cleaves onl4T a2, 3 and a2, 8 linkages) indicated that 85% was [ H]Siaa2-6GalP31-4Glc-4-MU. Because most, if not all, of the 9-0-acetylation in the native rat liver is found on Siaa2-6-lactosamine units , this sialylated product should be an acceptor for the O-acetyltransferase (we had shown previously in Higa et al. [1989] that even free sialic acid can act as an acceptor for the rat liver O-acetyltransferase). Moreover, this residues. After release by A. ureafaciens sialidase, the [3H]Sias were purified and studied. As shown in Figure 9 , -85% of the 3H-label had the same mobility of unmodified Sia, whereas a second peak comprising -10-15% of the material had the mobility of 9-0-acetylated-Sias. However, this peak was also seen in the absence of added unlabeled acetyl-CoA. Furthermore, it is completely resistant to base treatment (Figure 9) , indicating that it is not a 9-0-acetylated species. Similar base-resistant sialic acids of unknown identity were previously noted in the endogenous acceptors labeled by CMP-[3H]Sia in the same type of Golgi preparations (Hayes et al., 1993 6sialyltransferase and the CMP-Sia transporter. We therefore coincubated Golgi compartments with saturating amounts of 4-MU-lactoside (5 mM), CMP- [3HISia (1 ,uM) , and excess unlabeled acetyl-CoA (Diaz and Varki, unpublished observations) . Thus, although even free sialic acid can act as an 0-acetylation acceptor in vitro, membrane proteins seem to be selectively targeted in the intact Golgi preparations, suggesting that they are segregated into the compartment of 0-acetylation. In this regard, Saucan and Palade (1994) recently demonstrated that membrane-bound and secretory proteins in rat liver hepatocytes are transported from the Golgi apparatus to the cell surface via sets of different carriers. In their studies, the two types of vesicular carriers could be defined by immunoisolation with an antibody directed against the cytosolic tail of the polymeric IgA receptor (pIgA-R), immobilized on magnetic beads. Membrane-bound proteins were segregated in pIgA-R-positive vesicles, whereas secretory proteins were primarily present in pIgA-R-negative vesicles (Saucan and Palade, 1994) . In these studies, the majority of proteins (80-90%) is found in pIgA-R-negative fraction.
We tested whether 0-acetylated sialoglycoproteins were differentially distributed between these two distinct populations of carrier vesicles. The vesicles were prepared from rat liver and subjected to immunoisolation exactly as described earlier (Saucan and Palade, 1994) . Proteins of the starting material (SM), nonbound vesicles (NB), and bound (B) vesicles were separated by SDS-PAGE and then transferred to nitrocellulose. Figure 10 , left panel, shows a Western blot with an anti-pIgA-R antibody as a control for the immunoisolation procedure, confirming the enrichment of pIgA-R in the bound fraction. Figure 10 , middle panel, shows the distribution of total sialylated proteins in the fractions probed with the Sambucus nigra agglutinin, which recognizes Sia in a2,6-linkages (Shibuya et al., 1989) . Sialylated molecules were noted in both fractions, although some enrichment in the bound fraction was observed. As shown in Figure 10 (right panel), 9-0-acetylated sialoglycoproteins were selectively segregated into the pIgA-R-positive fraction despite the fact that it contained only 10-20% of the total protein. Given the incompleteness of this immunofractionation protocol (Figure 10 , left panel), it is impossible to define whether complete segregation occurs. Regardless, it is likely that 0-acetylation occurs primarily after the completion of sialylation, only on the subset of proteins destined for the plasma membrane. It remains to be determined whether this 0-acetylation event occurs before or after the segregation of this subset of proteins from others destined for secretion. (Saucan and Palade, 1994 
DISCUSSION
Sequential modifications of N-linked sugar chains occurring on newly synthesized glycoproteins have long been used as signposts for the organization of the Golgi apparatus. There is little doubt that the enzymes that work early in the pathway are found mainly in the earlier (cis and medial) regions of the Golgi, whereas those acting later tend to occur in the trans stacks and the trans-Golgi network. The original model, in which each major step of the pathway was confined to a discrete stack of the Golgi (Goldberg and Kornfeld, 1983; Quinn et al., 1983; Griffiths and Simons, 1986) , has given way to the realization that there can be some overlap in the distribution of the enzymes in a cell-type-dependent way (Roth et al., 1986; Mellman and Simons, 1992; Hayes et al., 1993; Hayes and Varki, 1993b; Nilsson et al., 1993; Velasco et al., 1993) . Furthermore, the presence of a given enzyme in a particular Golgi stack does not mean that it actually functions in that location (Hayes et al., 1993) . Given the cytosolic location of sugar nucleotide donor synthesis and the rapid rate of transport through the stacks, several other factors are relevant, including the specific membrane antiporters that translocate donors into the lumen of the compartments (Hirschberg and Snider, 1987; Milla and Hirschberg, 1989) , the presence of enzymes that degrade these donors (Martina et al., 1995) , and the availability of the correct biosynthetic intermediate as an acceptor (Hayes et al., 1993) . One way to dissect the relative importance of these factors is to prevent or inhibit transport and then examine the biosynthetic capabilities of the individual compartments. If these compartments are prepared directly from chilled fresh tissues, they should contain endogenous acceptors arrested in transit, in compartments where they could receive further modifications. Adding labeled donor nucleotides to these preparations reinitiates the process of uptake and incorporation in a cytosol-free situation in which intercompartmental transport cannot occur. Indeed, fresh Golgi preparations from rat liver (Hayes et al., 1993; Etchison et al., 1995) , melanoma cells (Sjoberg and Varki, 1993) , and rat retina (Maxzuid et al., 1995) do allow such a "freeze-frame" analysis. The radioactive sugar nucleotide donors are concentrated within intact compartments whose biosynthetic capabilities are far superior to any broken ones present in the same preparation. This is proven by the observations that 1) detergents decrease rather than increase the efficiency of labeling, and 2) endogenous products are protected from added proteases (Hayes et al., 1993) . Studies using this approach have shown both the expected biosynthetic intermediates as well as several unexpected products (Hayes et al., 1993; Hayes and Varki, 1993a,b) . Also, in Golgi fractions from rat liver, evidence was found for functional overlap of GlcNAc-transferases, galactosyltransferases, and sialyltransferases (Hayes and Varki, 1993b) . In those papers, we also indicated why potential mixing of compartments during homogenization is not a major confounding factor. A disadvantage of this approach is that the Golgi compartments are studied as a mixture and cannot be physically separated. Although each compartment defines itself functionally (making the study of the products valid), it was impossible to visualize the location of the products. Here we present some approaches to circumvent this deficiency and show that the 0-acetylation of Sias occurs primarily in a compartment distal to, and distinct from, the compartments where Sia addition itself takes place.
Using a modified sugar donor (CMP-Sia-FITC) recognized by both the CMP-sialic acid transporter (Gross, 1992) and the major rat liver sialyltransferases (Gross and Brossmer, 1988) , we visualize the functional compartments of isolated Golgi stacks where sialylation takes place; these are mostly distinct from sites where 0-acetylation of sialic acids is found. This principle could be extended to any nucleotide donor in which a detectable sugar modification does not cause loss of recognition by the nucleotide transporter and/or the relevant sugar transferases.
The sites of sialylation in the Golgi apparatus (mainly trans-Golgi and TGN) are generally considered the last stations of the Golgi apparatus through which a glycoprotein must pass. However, 0-acetylation of sialic acids occurs after the transfer of sialic acids to glycoproteins , and previous indirect evidence suggested it might occur in a distinct compartment (Hayes and Varki, 1993b) . Until now, it was not possible to address this matter directly because of the lack of a reliable probe for detecting the 0-acetyltransferase or its product. The latter can now be detected with an Influenza C hemagglutinin-esterasederived recombinant probe (Klein et al., 1994) called CHE-FcD. Here we show that, although there is some overlap between the distribution of the a2-6sialyl-transferase antigen and the endogenous 9-0-acetylated sialic acids, there is very little overlap between the products of the sialylation and 0-acetylation reactions, even when both reactions are driven to completion with an in vitro incubation. It is unlikely that this result is an artifact of the system used. First, the rates of sialylation and 0-acetylation in this system were previously shown to be relatively similar , indicating that the availability of endogenous acceptors is not limiting. Furthermore, we show a clear overlap between the two immediately earlier steps in the pathway-galactosylation and sialylation. Finally, a similar result was obtained with an exogenous acceptor capable of penetrating into all of the stacks.
Some subtleties of 0-acetylation deserve comment. We have noted that, in the rat liver Golgi, 0-acetylation occurs at both the 7-and the 9-positions of endogenous sialic acids Butor et al., 1993) . The 7-0-acetyl groups can then migrate to the 9-position under mildly alkaline conditions. It is currently not known whether the 7-0-acetylated product can be recognized by the CHE-FcD probe. If not, a discrete 7-0-acetyltransferase reaction that overlaps with the sialylation could have been missed in this study. Another possibility is that the same 0-acetyltransferase transfers to both positions and that the detection of the 9-0-acetylated product therefore localizes both reactions. Indirect evidence also suggests that there may be multiple sialate/O-acetyltransferases with differing specificities, depending on the nature of the glycoconjugate and/or the linkage of the Sia residue (reviewed in references of Varki, 1992) . Thus, the results obtained here should not be extrapolated to other cell types in which sialic acids are 9(7)-O-acetylated. Indeed, our earlier work suggests that 0-acetylation of the terminal Sia residue of ganglioside GD3 is not segregated from the compartment of sialylation in human melanoma cells (Sjoberg and Varki, 1993) .
The data presented here suggest discrete compartments for sialylation and 0-acetylation reactions in rat liver Golgi. It is possible that distinct subdomains within the trans-Golgi stacks and TGN might selectively harbor functional complexes of all the compo-nents required for each reaction. Although such functional complexes have been detected in the medial Golgi (Nilsson et al., 1994) , none have been convincingly demonstrated to date in the trans Golgi. Perhaps the 0-acetyltransferase machinery is selectively located at the exit point from the trans-Golgi network and is functionally expressed only in a subset of budding vesicles. This fits our observation that 0-acetylated glycoproteins are selectively found in the subfraction of vesicular carriers enriched in plasma membrane proteins. Further work is needed to know whether 0-acetylation is the cause or the consequence of the formation of these carriers. The use of glycosides as alternate acceptors for glycosylation reactions is well established for intact cells (Lugemwa and Esko, 1991; Freeze et al., 1993) . In such studies, derivatives such as 4-methylumbelliferyl (4-MU) ,3-glycosides added to the culture medium must penetrate two barriers: the plasma membrane and the membrane of the Golgi compartments. However, Freeze and colleagues (Etchison et al., 1995) have shown that monosaccharide glycosides can also be added directly to intact Golgi compartments. Here we have used a disaccharide glycoside as an exogenous acceptor that successfully penetrated the Golgi membrane. Interestingly, Esko and colleagues have recently shown that, for disaccharide glycosides to enter the Golgi of intact cells, it is necessary to modify them to increase their hydrophobicity (Sarkar et al., 1995) . This implies that the Golgi membrane may be relatively more permeable to small saccharides than the plasma membrane. In keeping with this, when a ,3-xyloside was added to intact Golgi, one of the products (Galf31-4xyloside) was found to diffuse back out of the Golgi compartments at a significant rate (Etchison et al., 1995) . However, the further addition of sialic acid caused the molecule to be irreversibly trapped in the Golgi lumen (Etchison et al., 1995) .
Because the exogenous lactoside acceptor can enter all compartments in excess, the overlap between the sialylation and 0-acetylation compartments should have been seen, if it existed. Although no 0-acetylation was seen, we did observe an unusual base-resistant modification of the sialic acids that were transferred to the lactoside derivatives. The nature of this modification, which occurs during the short in vitro incubation, remains unknown. It does serve to emphasize that 0-acetylation is only one of many possible modifications of sialic acids observed in biological systems (Varki, 1992) . Identification of the subcellular sites at which these modifications are synthesized should provide useful signposts for understanding the organization and function of the Golgi apparatus and the exocytic pathway.
